Please assess the completion status of the following clinical trial:

Trial Title: Patient Satisfaction and Sensory Attributes Allergic Rhinitis Nasal Spray

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Allergic Rhinitis patients (moderate-to-severe Seasonal Allergic Rhinitis or Perennial Allergic Rhinitis) with or without conjunctivitis who meet the following criteria will be offered the opportunity to participate in the study:~* Patients above 18 years old~* Fluent in English~* Patients initiated on RYALTRIS® or DYMISTA® nasal spray in the last 12 months and currently using treatment~* Willing and able to provide consent to participate~Exclusion Criteria:~* Have reported a loss of taste and/or smell related to COVID-19 (or other medical condition)~* Are employed by a pharmaceutical company (to avoid conflict of interest)~* Are employed by a vaccine company (to avoid conflict of interest)~* Do not have access to the internet (to ensure validity of the data)~* Are unable to read and understand English (to ensure validity of the data)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Patients on RYALTRIS (Type: None): Patients who are currently using RYALTRIS nasal spray.
- Patients on DYMISTA (Type: None): Patients who are currently using DYMISTA nasal spray.

Based on this trial design, predict the completion outcome and termination type (if applicable).